Your answers help determine which program characteristics matter most for your specific situation: Have you discussed GLP-1 medication with your primary care provider or another clinician who knows your full medical history
But the increasing diversity of options is good news for anyone who needs the metabolic benefits of GLP-1 receptor agonists but struggles with psychiatric tolerability on current options
Naltrexone-bupropion combines opioid antagonism with dopamine and norepinephrine reuptake inhibition to modulate hunger and reward centers
For example, a novel dual agonist of GLP-1/GIP receptors significantly increased BDNF levels in a mouse model of Parkinsons disease, induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration [53]
These same principles apply to other injectable peptides as well
While most trials show no benefit, some research shows that magnesium supplementation may be linked to a slightly lower waist circumference in people who have obesity